Results 271 to 280 of about 72,749 (293)
Some of the next articles are maybe not open access.
2013
Advances in the field of stents have revolutionised the treatment of coronary artery diseases. To provide effective treatment for coronary artery disease, a stent has to be deliverable and flexible, cause minimal trauma to the vessel wall, cause minimal inflammatory reaction, endothelialise well, provide scaffolding for the vessel, and finally promote ...
Abraham J. Domb +4 more
openaire +2 more sources
Advances in the field of stents have revolutionised the treatment of coronary artery diseases. To provide effective treatment for coronary artery disease, a stent has to be deliverable and flexible, cause minimal trauma to the vessel wall, cause minimal inflammatory reaction, endothelialise well, provide scaffolding for the vessel, and finally promote ...
Abraham J. Domb +4 more
openaire +2 more sources
The American Journal of Cardiology, 2007
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. This led to early adoption and high penetration of DES use in percutaneous coronary intervention (PCI). Outcomes have not demonstrated an improvement in the hard end points of death and myocardial infarction with these devices, but repeat procedures for ...
Tina L. Pinto Slottow, Ron Waksman
openaire +3 more sources
Drug-eluting stents (DESs) held the promise of mitigating, if not abolishing, in-stent restenosis. This led to early adoption and high penetration of DES use in percutaneous coronary intervention (PCI). Outcomes have not demonstrated an improvement in the hard end points of death and myocardial infarction with these devices, but repeat procedures for ...
Tina L. Pinto Slottow, Ron Waksman
openaire +3 more sources
Stent Coating Integrity of Durable and Biodegradable Coated Drug Eluting Stents.
Journal of interventional cardiology, 2016BACKGROUND Coatings consisting of a polymer and drug are widely used in drug-eluting stents (DES) and are essential in providing programmable drug release kinetics. Among other factors, stent coating technologies can influence blood compatibility, affect
S. Yazdani +5 more
semanticscholar +1 more source
Drug Eluting Stents and Beyond
Current Pharmaceutical Design, 2008The present review discusses the mechanism of late stent thrombosis and its distinction from restenosis and summarizes the advisory note issued by FDA on the proper usage of different treatments available for atherosclerosis. In light of the latest developments, a plethora of new stents have been and continue to be developed globally. Hence, there is a
Ashish Rastogi, Salomon A Stavchansky
openaire +3 more sources
From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI
Expert Review of Medical Devices, 2016Drug eluting stents and particularly the fully bioresorbable drug-eluting scaffolds herald a new era in percutaneous treatment of coronary artery disease. There has been tremendous progress in drug eluting stents with fully biodegradable coating polymers
E. Tenekecioğlu +9 more
semanticscholar +1 more source
Current Problems in Cardiology, 2006
The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty.
David R. Holmes +2 more
openaire +3 more sources
The introduction and widespread use of coronary stents have been the most important advancement in the percutaneous treatment of coronary artery disease since the introduction of balloon angioplasty. Coronary artery stents reduce the rate of angiographic and clinical restenosis compared to balloon angioplasty.
David R. Holmes +2 more
openaire +3 more sources
ACS Applied Materials and Interfaces, 2015
Drug-eluting stents (DES) have become more widely used by cardiologists than bare metal stents (BMS) because of their better ability to control restenosis.
T. Hu +8 more
semanticscholar +1 more source
Drug-eluting stents (DES) have become more widely used by cardiologists than bare metal stents (BMS) because of their better ability to control restenosis.
T. Hu +8 more
semanticscholar +1 more source
Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes.
Cochrane Database of Systematic Reviews, 2015BACKGROUND Coronary artery stents are tiny tubular devices used to 'scaffold' vessels open during percutaneous transluminal coronary angioplasty (PTCA). Restenosis (re-narrowing) of vessels treated with stents is a problem; in order to reduce restenosis,
J. Greenhalgh +5 more
semanticscholar +1 more source
2003
Over the last decade, the most radical change in percutaneous coronary intervention (PCI) practice has been the rapid incorporation of intracoronary stenting, to the extent that it is now used in well over 80% of all angioplasty procedures. This change in practice has occurred as a consequence of landmark studies, such as STRESS (Stent Restenosis Study)
R S More, A. Chauhan
openaire +2 more sources
Over the last decade, the most radical change in percutaneous coronary intervention (PCI) practice has been the rapid incorporation of intracoronary stenting, to the extent that it is now used in well over 80% of all angioplasty procedures. This change in practice has occurred as a consequence of landmark studies, such as STRESS (Stent Restenosis Study)
R S More, A. Chauhan
openaire +2 more sources